Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate

References

• Belle LP, Bitencourt PER, Abdalla FH, Guerra RB, Funchal C, Moretto MB. 2011. An in vitro comparison of a new vinyl chalcogenide and sodium selenate on adenosine deaminase activity of human leukocytes. Chem Biol Interact. 189(3):141–145.
   PubMed Web of Science ®Google Scholar
• Borges RLO, Ribeiro AB, Zanella MT, Batista MC. 2010. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep. 12(2):113–119.
   PubMed Web of Science ®Google Scholar
• Borges F, Fernandes E, Roleira F. 2002. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem. 9(2):195–217.
   PubMed Web of Science ®Google Scholar
• Carro MD, Falkenstein E, Radke WJ, Klandorf H. 2010. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens. Comp Biochem Phys C. 151(1):12–17.
   PubMed Web of Science ®Google Scholar
• Chen YS, Hu QH, Zhang X, Zhu Q, Kong LD. 2013. Beneficial effect of rutin on oxonate-induced hyperuricemia and renal dysfunction in mice. Pharmacology. 92(1–2):75–83.
   PubMed Web of Science ®Google Scholar
• Chen G, Tan ML, Li KK, Leung PC, Ko CH. 2015. Green tea polyphenols decrease uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice. J Ethnopharmacol. 175:14–20.
   PubMed Web of Science ®Google Scholar
• Fathallah SS, Cramer M. 2014. Uric acid and the kidney. Pediatr Nephrol. 29(6):999–1008.
   PubMed Web of Science ®Google Scholar
• Fu M, Fu S, Ni S, Zou L, Liu Y, Hong T. 2017. Anti-inflammatory effect of epigallocatechin gallate in a mouse model of ovalbumin-induced allergic rhinitis. Int Immunopharmacol. 49:102–108.
   PubMed Web of Science ®Google Scholar
• Guo J, Ting LI, Jin C, Qian XU, Jiang TT, Huang LS, Lin YN. 2017. Influence of glycerol/water solution on ginsenosides Rg1 bioavailability in rats. Strait Pharm J. 29:32–35.
   Google Scholar
• Hoffmann D, Fuchs TC, Henzler T, Matheis KA, Herget T, Dekant W, Hewitt P, Mally A. 2010. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology. 277(1–3):49–58.
   PubMed Web of Science ®Google Scholar
• Kawano Y. 2011. Uric acid and blood pressure. Circ J. 75(12):2755–2756.
   PubMed Web of Science ®Google Scholar
• Khan N, Mukhtar H. 2007. Tea polyphenols for health promotion. Life Sci. 81:0–533.
   Web of Science ®Google Scholar
• Krook MA, Hagerman AE. 2012. Stability of polyphenols epigallocatechin gallate and pentagalloyl glucose in a simulated digestive system. Food Res Int. 49(1):112–116.
   PubMed Web of Science ®Google Scholar
• Kurra V, Eräranta A, Jolma P, Vehmas TI, Riutta A, Moilanen E, Tahvanainen A, Kalliovalkama J, Niemelä O, Myllymäki J, et al. 2009. Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency. Am J Hypertens. 22(9):964–970.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Lee M-J, Diamond L, Ju J, Hong J, Bose M, Newmark HL, Yang CS. 2006. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab Dispos. 34(1):8–11.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lee HJ, Kang KS, Lee CY. 2002. Preventive effects of vitamin C on carcinogenesis. Lancet. 359(9301):172–172.
   PubMed Web of Science ®Google Scholar
• Li M, Hu X, Fan Y, Li K, Zhang X, Hou W, Tang Z. 2016. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 6:19520.
   PubMed Web of Science ®Google Scholar
• Li N, Taylor LS, Ferruzzi MG, Mauer LJ. 2012. Kinetic study of catechin stability: effects of pH, concentration, and temperature. J Agric Food Chem. 60(51):12531–12539.
   PubMed Web of Science ®Google Scholar
• Luo KW, Wei Chen Lung W-Y, Wei X-Y, Cheng B-H, Cai Z-M, et al. 2017. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. J Nutr Biochem. 41:56–64.
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G, Borghi C. 2015. Hyperuricemia, urate deposition and the association with hypertension. Curr Med Res Opin. 31(sup2):15–19.
   PubMedGoogle Scholar
• Masuda M, Suzui M, Jin TEL, Deguchi A, Soh JW, Weinstein IB. 2002. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol. 2(6):350–359.
   PubMedGoogle Scholar
• Mereles D, Hunstein W. 2011. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci. 12(9):5592–5603.
   PubMed Web of Science ®Google Scholar
• Nagle DG, Ferreira D, Zhou Y-D. 2006. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry. 67(17):1849–1855.
   PubMed Web of Science ®Google Scholar
• Sang S, Lee M-J, Hou Z, Ho C-T, Yang CS. 2005. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem. 53(24):9478–9484.
   PubMed Web of Science ®Google Scholar
• Sato M, Mamada H, Anzai N, Shirasaka Y, Nakanishi T, Tamai I. 2010. Renal secretion of uric acid by organic anion transporter 2 (oat2/slc22a7) in human. Biol Pharm Bull. 33(3):498–503.
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Norquist JM, Watson DJ. 2009. Serum urate during acute gout. J Rheumatol. 36(6):1287–1289.
   PubMed Web of Science ®Google Scholar
• Tai LL, Liu ZH, Sun MH, Xie QJ, Cai XQ, Wang Y, Dong X, Xu Y. 2020. Anti-hyperuricemic effects of three theaflavins isolated from black tea in hyperuricemic mice. J Funct Foods. 66:1–9.
   Web of Science ®Google Scholar
• Vazquez-Mellado J. 2001. Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis. 60(10):981–983.
   PubMed Web of Science ®Google Scholar
• Woodward OM. 2015. ABCG2: the molecular mechanisms of urate secretion and gout. Am J Physiol-Renal. 309(6):F485–F488.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang J, Deng F, Hu Z, Wang H. 2008. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res. 78(3):242–249.
   PubMed Web of Science ®Google Scholar
• Yan M, Yang J, Li S, Yu W. 2018. Synergic inhibition of lung carcinoma 95-D cell proliferation and invasion by combination with (−)-epigallocatechin-3-gallate and ascorbic acid. Wuhan Univ J Nat Sci. 23(3):270–276.
   Google Scholar
• Yang JH. 2012. Research progress in biological activities of vitamin C. Mod Digan Treat. 23:434–437.
   Google Scholar
• Zhu C, Xu Y, Liu Z-H, Wan X-C, Li D-X, Tai L-L. 2018. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice. Biomed Pharmacother. 97:168–173.
   PubMed Web of Science ®Google Scholar
• Zhu QY, Hammerstone JF, Lazarus SA, Schmitz HH, Keen CL. 2003. Stabilizing effect of ascorbic acid on flavan-3-ols and dimeric procyanidins from cocoa. J Agric Food Chem. 51(3):828–833.
   PubMed Web of Science ®Google Scholar
• Zimeri J, Tong CH. 1999. Degradation kinetics of (–)-epigallocatechin gallate as a function of pH and dissolved oxygen in a liquid model system. J Food Science. 64(5):753–758.
   Web of Science ®Google Scholar